United Orthopedic Corporation

TPEX:4129 Stock Report

Market Cap: NT$8.9b

United Orthopedic Future Growth

Future criteria checks 1/6

United Orthopedic is forecast to grow revenue at 16.6% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth22.4%
Revenue growth rate16.6%
Future return on equityn/a
Analyst coverage

Low

Last updated22 Nov 2024

Recent future growth updates

Recent updates

Calculating The Fair Value Of United Orthopedic Corporation (GTSM:4129)

Apr 26
Calculating The Fair Value Of United Orthopedic Corporation (GTSM:4129)

United Orthopedic (GTSM:4129) Could Be Struggling To Allocate Capital

Apr 12
United Orthopedic (GTSM:4129) Could Be Struggling To Allocate Capital

What Type Of Returns Would United Orthopedic's(GTSM:4129) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Mar 08
What Type Of Returns Would United Orthopedic's(GTSM:4129) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Is United Orthopedic (GTSM:4129) A Risky Investment?

Feb 16
Is United Orthopedic (GTSM:4129) A Risky Investment?

Does United Orthopedic Corporation (GTSM:4129) Have A Place In Your Dividend Stock Portfolio?

Jan 29
Does United Orthopedic Corporation (GTSM:4129) Have A Place In Your Dividend Stock Portfolio?

Our Take On The Returns On Capital At United Orthopedic (GTSM:4129)

Jan 11
Our Take On The Returns On Capital At United Orthopedic (GTSM:4129)

Does United Orthopedic Corporation's (GTSM:4129) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

Dec 24
Does United Orthopedic Corporation's (GTSM:4129) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

How Much Did United Orthopedic's(GTSM:4129) Shareholders Earn From Share Price Movements Over The Last Five Years?

Dec 03
How Much Did United Orthopedic's(GTSM:4129) Shareholders Earn From Share Price Movements Over The Last Five Years?

Earnings and Revenue Growth Forecasts

TPEX:4129 - Analysts future estimates and past financials data (TWD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20255,490N/A5491,0853
12/31/20244,706N/A6281,1281
9/30/20244,471454-22624N/A
6/30/20244,275428-139445N/A
3/31/20244,068407-195367N/A
12/31/20233,930380-124434N/A
9/30/20233,721342-167340N/A
6/30/20233,546308-106350N/A
3/31/20233,357252-83320N/A
12/31/20223,169222-29357N/A
9/30/20222,973173-20322N/A
6/30/20222,83298106427N/A
3/31/20222,68470145414N/A
12/31/20212,57129115342N/A
9/30/20212,52044248471N/A
6/30/20212,55178256492N/A
3/31/20212,44686260499N/A
12/31/20202,34278269501N/A
9/30/20202,31036136384N/A
6/30/20202,2401364271N/A
3/31/20202,39656121367N/A
12/31/20192,43784225519N/A
9/30/20192,393131226521N/A
6/30/20192,327132-1337N/A
3/31/20192,320116-179199N/A
12/31/20182,332128-35918N/A
9/30/20182,277100-616-84N/A
6/30/20182,284107N/A-216N/A
3/31/20182,187160N/A-481N/A
12/31/20171,973130N/A22N/A
9/30/20171,803139N/A110N/A
6/30/20171,577106N/A354N/A
3/31/20171,39361N/A532N/A
12/31/20161,383147N/A183N/A
9/30/20161,379138N/A163N/A
6/30/20161,407186N/A215N/A
3/31/20161,437198N/A319N/A
12/31/20151,393134N/A253N/A
9/30/20151,330135N/A233N/A
6/30/20151,271113N/A199N/A
3/31/20151,14372N/A145N/A
12/31/20141,10182N/A93N/A
9/30/20141,04452N/A58N/A
6/30/201499725N/A6N/A
3/31/201498531N/A-19N/A
12/31/201395621N/A11N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 4129's forecast earnings growth is above the savings rate (1.1%).

Earnings vs Market: Insufficient data to determine if 4129's earnings are forecast to grow faster than the TW market

High Growth Earnings: Insufficient data to determine if 4129's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 4129's revenue (16.6% per year) is forecast to grow faster than the TW market (12.1% per year).

High Growth Revenue: 4129's revenue (16.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 4129's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 09:52
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

United Orthopedic Corporation is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pinghan HsiehCapital Securities Corporation
Jennie TsaiG. Research, LLC
Zhennan LeeJih Sun Securities Investment Consulting Co., Ltd.